We sought to investigate the prevalence of PIK3CA mutations in Lebanese GBM patients and found that there were 16 PIK3CA mutations distributed among 13 patients, accounting for 21.7% of all patients (95% CI: 11.2–32.1). Here, PIK3CA is linked to glioblastoma.